Atalanta Therapeutics logo

Atalanta Therapeutics

Website

Team & Investors

Leadership, board of directors, and investment partners

Executives
0
Board Members
0
Investors
11
Total Funding
$227M
Investors
11 investors across all rounds
AI
Aberdeen Investments (Scotland)
B
Biogen
EL
EQT Life Sciences
VENTURE_CAPITAL
FC
F-Prime Capital
VENTURE_CAPITAL
G
Genentech

+6 more investors

Sign in to view all

Explore More Data
Detailed analysis for Atalanta Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

Atalanta Therapeutics Leadership & Investors

Atalanta Therapeutics is led by a team of experienced leaders. The company has attracted investment from 11 institutional and strategic investors.

Who Has Invested in Atalanta Therapeutics?

Atalanta Therapeutics has raised $227M from 11 investors including venture capital firms, private equity investors, and strategic partners.

Investment Opportunity

Accredited investors can access Atalanta Therapeutics shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.